Cargando…

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer.

We have assessed the pharmacokinetics, pharmacological and anti-tumour effects of the specific steroidal anti-oestrogen ICI 182780 in 19 patients with advanced breast cancer resistant to tamoxifen. The agent was administered as a monthly depot intramuscular injection. Peak levels of ICI 182780 occur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howell, A., DeFriend, D. J., Robertson, J. F., Blamey, R. W., Anderson, L., Anderson, E., Sutcliffe, F. A., Walton, P.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074590/ https://www.ncbi.nlm.nih.gov/pubmed/8688341

Ejemplares similares

Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
por: DeFriend, D. J., et al.
Publicado: (1994)

ICI 182,780 (Fulvestrant™) – the first oestrogen receptor down-regulator – current clinical data
por: Robertson, J F R
Publicado: (2001)

Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism
por: Kendall, Sherie L, et al.
Publicado: (2005)

Response in post-menopausal patients on ICI 118630.
por: Robertson, J. F., et al.
Publicado: (1987)

ICI 182,780 has agonistic effects and synergizes with estradiol-17 beta in fish liver, but not in testis
por: Pinto, Patrícia IS, et al.
Publicado: (2006)

Effects of ICI 182780 on estrogen receptor expression, fluid absorption and sperm motility in the epididymis of the bonnet monkey
por: Shayu, Deshpande, et al.
Publicado: (2005)

Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines
por: Woode, Denzel R., et al.
Publicado: (2012)

A transcriptomics model of estrogen action in the ovine fetal hypothalamus: evidence for estrogenic effects of ICI 182,780
por: Rabaglino, Maria Belen, et al.
Publicado: (2018)

ICI 182,780 Attenuates Selective Upregulation of Uterine Artery Cystathionine β-Synthase Expression in Rat Pregnancy
por: Bai, Jin, et al.
Publicado: (2023)

Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182(R)-6
por: Jensen, B L, et al.
Publicado: (1999)

17β-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct Outcomes
por: Jallow, Fatou, et al.
Publicado: (2018)

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
por: Cole, M. P., et al.
Publicado: (1971)

The anti-estrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF7 breast cancer cells refractory to long-term estrogen deprivation through downregulation of ER and IGF signalling
por: Martin, L-A, et al.
Publicado: (2005)

Effects of ICI 182,780, an ERα and ERβ antagonist, and G-1, a GPER agonist, on autophagy in breast cancer cells
por: Muler, Mari Luminosa, et al.
Publicado: (2020)

Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations
por: Bramley, M, et al.
Publicado: (2006)

The antiestrogen ICI 182,780 induces early effects on the adult male mouse reproductive tract and long-term decreased fertility without testicular atrophy
por: Cho, Hyun Wook, et al.
Publicado: (2003)

The antiestrogen ICI 182,780 decreases the expression of estrogen receptor-alpha but has no effect on estrogen receptor-beta and androgen receptor in rat efferent ductules
por: Oliveira, Cleida A, et al.
Publicado: (2003)

Tumour epithelial cellularity and quantitative oestrogen receptor values in primary breast cancer.
por: Mumford, C. J., et al.
Publicado: (1983)

Reduction of post injury neointima formation due to 17β-estradiol and phytoestrogen treatment is not influenced by the pure synthetic estrogen receptor antagonist ICI 182,780 in vitro
por: Finking, Gerald, et al.
Publicado: (2002)

Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells
por: Okubo, S, et al.
Publicado: (2004)

Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.
por: Maynard, P. V., et al.
Publicado: (1978)

Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist.
por: Nicholson, R. I., et al.
Publicado: (1979)

Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
por: Robertson, J. F., et al.
Publicado: (1992)

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
por: Clarke, R. B., et al.
Publicado: (1993)

Fulvestrant: pharmacokinetics and pharmacology
por: Robertson, J F R, et al.
Publicado: (2004)

Oestrogen receptors in primary breast cancer.
por: Williams, M. R., et al.
Publicado: (1985)

Oestrogen-receptor status and sites of metastasis in breast cancer.
por: Campbell, F. C., et al.
Publicado: (1981)

Oestrogen‐activated autophagy has a negative effect on the anti‐osteoclastogenic function of oestrogen
por: Cheng, Liang, et al.
Publicado: (2020)

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
por: Williams, M. R., et al.
Publicado: (1986)

Objective measurement of therapeutic response in breast cancer using tumour markers.
por: Robertson, J. F., et al.
Publicado: (1991)

Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2
por: Kunisue, H, et al.
Publicado: (2000)

Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.
por: McClelland, R. A., et al.
Publicado: (1998)

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts.
por: Colletta, A. A., et al.
Publicado: (1990)

Isolation and identification of three new chromones from the leaves of Pimenta dioica with cytotoxic, oestrogenic and anti-oestrogenic effects
por: Doyle, Brian J., et al.
Publicado: (2018)

Pharmacokinetic studies in mice with ICI D0490, a novel recombinant ricin A-chain immunotoxin.
por: Calvete, J. A., et al.
Publicado: (1993)

The novel anti-oestrogen idoxifene inhibits the growth of human MCF-7 breast cancer xenografts and reduces the frequency of acquired anti-oestrogen resistance.
por: Johnston, S. R., et al.
Publicado: (1997)

Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells
por: Borley, Annabel C, et al.
Publicado: (2008)

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer
por: van Agthoven, T, et al.
Publicado: (2009)

Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
por: Skliris, G P, et al.
Publicado: (2006)

Oestrogen receptor: a stable phenotype in breast cancer.
por: Robertson, J. F.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_h0b7k7o3tu5hil2jhul9eoli3g